Search

You searched for "malware"

414 results found

What's trending Feb/Mar 2021

4 February 2021 | | Ophthalmology, Optometry, Cornea / External Eye Disease, Orbit, Retina / Uvea / Vitreous
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. Happy New Year! Goodbye 2020, a year no one could have imagined, with our lives and headlines dominated by COVID-19 as...

The approach to trabeculectomy postoperative complications

1 August 2016 | | Glaucoma
Performing a trabeculectomy is like giving birth to a baby. It may be traumatic and there is scope for devastating error but once the operation is completed only then does the real work begin. The bleb must be nurtured into...

Should we move towards procedure-specific consent forms?

1 October 2017 | | Cataract and Refractive, Cornea / External Eye Disease, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous, AMD, Emergency Ophthalmology
The consent process represents the patient’s acceptance of the information provided to them and an agreement to undergo an intervention as suggested by a health professional. Effective doctor-patient communication, ensuring the succinct delivery of the necessary points in a way...

Bridging the gap – Supporting our patients across the primary / secondary care divide

1 June 2017 | Optometry
Providing the best care for patients is surely a fundamental goal for all healthcare professionals. When waiting-times are long and getting longer, clinics are full, colleagues are off with stress-related illness and patients are complaining, is it possible to still...

Visual disturbance heralding stroke: are we seeing the signs in time?

6 April 2021 | | Ophthalmology, Neuro-Ophthalmology, Optometry
Isolated visual symptoms may be an early presenting feature of stroke, and timely recognition of such atypical cases is important because treatment for stroke has a limited time-window of efficacy. Stroke occurs in approximately 150,000 people per year in the...

“I can see fine. Why do I need my eyes tested?”

2 December 2019 | | Optometry
Are routine eye examinations really necessary? The author asks whether frequent appointments in low-risk patients with normal results are actually cost-effective. It’s recommended that most people should get their eyes tested every two years.” [1] This message is widely publicised...

Neuro-ophthalmic disease patterns in Southeast Asia with particular reference to giant cell arteritis

1 April 2016 | | Neuro-Ophthalmology
As indicated in an earlier article in Eye News [1] Dr Cullen was invited in 2000 to the Singapore National Eye Centre (SNEC) as visiting Professor with a specific remit to set up a specialist neuro-ophthalmology service, which was the...

Biometry and IOL choice errors

1 April 2018 | Cataract and Refractive
In the next instalment of this series I focus on problems associated with biometry and intraocular lens (IOL) selection for cataract surgery. I have taken previous medicolegal cases I have dealt with and tried to extract some learning points and...

The most frequent complaints and claims in ophthalmology – a Medical Protection Society (MPS) analysis

4 December 2018 | | Optometry, Cataract and Refractive, Glaucoma
The authors look at the reasons behind medico-legal cases reported to MPS and share key learning points. Complications following ophthalmology surgery are rare, however, medico-legal cases are not uncommon due to the significant impact they can have on patients’ lifestyles....

Cataract surgery training in the independent sector

3 June 2024 | | Cataract and Refractive
I am now most of the way through my ST3 year working in Plymouth, within the Peninsula Deanery. Before the start of the year, I was approached by one of my consultants who asked if I would like to carry...

Advances and developments in medical retina

1 February 2019 | | Ophthalmology, Retina / Uvea / Vitreous
The author provides an update on late breaking clinical trial results in neovascular age-related macular degeneration (nAMD) and presentations on diabetes management from the American Academy of Ophthalmology Retina Subspecialty Day, held during the Academy’s annual meeting in Chicago, October...

Renewed momentum in ocular gene and cell therapy, broadening application to chronic disease

5 February 2020 | | Ophthalmology, Retina / Uvea / Vitreous
Gene and cell therapies offer the prospect of ground-breaking new avenues for the treatment of diseases, reflected in a renewed explosion of interest and investment in retinal gene therapy. Rod McNeil reports recent clinical trial readouts across a diverse range...